Genmab — September 2020

[gentogen]

Thanks EL. Sounds good: "an oral presentation and live Q&A of the latest data from the Phase 1 dose escalation study investigating amivantamab " (from your link)

[E_L]

another deal- Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations https://investor.seattlegenetics.com/press-releases/news-details/2020/Seattle-Genetics-and-Merck-Announce-Two-Strategic-Oncology-Collaborations/default.aspx SGEN up 17% pre-market

[nohope]

Fuck - BPx will run out of money before we get a decent +110 % offer for GEN.

[E_L]

money is for free,they'll never
run out of it

[E_L]

and another one, this time we are involved

[E_L]

SpringWorks Therapeutics Announces Clinical Collaboration with Janssen to Evaluate Nirogacestat in Combination with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma

[E_L]

https://newsfilter.io/articles/springworks-therapeutics-announces-clinical-collaboration-with-janssen-to-evaluate-nirogacestat-in-c-a627d89b1391f47d1e257661cecf0ea5

[E_L]

SpringWorks already works
with GSK on belantamab

[Helge_LarsenPI-redaktør]

Stockbull...Jeg tænker ud fra citatet ikke på aktiemarkedet, men alene realøkonomien.

[Solsen]

More ADC reals - SGEN and Merck https://finance.yahoo.com/news/seattle-genetics-merck-announce-two-104500702.html

[Solsen]

...deals

[nohope]

Ja, eller 2200

[Solsen]

Godt vi så ved at JW siger, at I ikke skal sælge

[Solsen]

Vi ved at JW har ambition om at blive et stort pharma med Genmab a la Regeneron eller Amgen. Hhv $60 og $145 bn....

[GeorgeBest]

Roche Pharma Day 2020 presentation https://www.roche.com/dam/jcr:c24e5b67-24be-4f06-9380-6c700540e4e9/en/irp20200914.pdf

[Helge_LarsenPI-redaktør]

amyloidosis Research Consortium

@Amyloidosis_ARC
· 3 t
Game changer for AL amyloidosis -Janssen Pharmaceutical has filed an application with the US Food and Drug Administration seeking approval for Darzalex Faspro to treat light chain (AL) amyloidosis. http://ow.ly/Di8a50Bq7Hg

[GeorgeBest]

Mosunetuzumab and glofitamab (CD20xCD3)
Potential first in class bispecifics in DLBCL and FL - se side 44 https://www.roche.com/dam/jcr:c24e5b67-24be-4f06-9380-6c700540e4e9/en/irp20200914.pdf

[GeorgeBest]

og igen side 66-68 / Roche har fart på, SC version præsenteres på ASH!

[Helge_LarsenPI-redaktør]

God morgen.

[bibob]

God morgen